SEC Form SC 13G/A filed by UiPath Inc. (Amendment)

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Schedule 13G
(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) 
AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b)

(Amendment No. 2)*

UiPath, Inc.

(Name of Issuer)

Class A common stock, par value $0.00001 per share

(Title of Class of Securities)

90364P105

(CUSIP Number)

December 31, 2023

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(Continued on following pages)

Page 1 of 21 Pages

Exhibit Index Contained on Page 18

(1) Based on 483,625,511 shares of Class A Common Stock outstanding as of December 1, 2023, as reported by the issuer in its Quarterly Report on Form 10-Q for the quarter ended October 31, 2023, filed with the Securities and Exchange Commission on December 4, 2023 (the “Form 10-Q”).

(1) Based on 483,625,511 shares of Class A Common Stock outstanding as of December 1, 2023, as reported by the issuer in the Form 10-Q.

(1) Based on 483,625,511 shares of Class A Common Stock outstanding as of December 1, 2023, as reported by the issuer in the Form 10-Q.

(1) Based on 483,625,511 shares of Class A Common Stock outstanding as of December 1, 2023, as reported by the issuer in the Form 10-Q.

(1) Based on 483,625,511 shares of Class A Common Stock outstanding as of December 1, 2023, as reported by the issuer in the Form 10-Q.

(1) Based on 483,625,511 shares of Class A Common Stock outstanding as of December 1, 2023, as reported by the issuer in the Form 10-Q.

(1) Based on 483,625,511 shares of Class A Common Stock outstanding as of December 1, 2023, as reported by the issuer in the Form 10-Q.

(1) Based on 483,625,511 shares of Class A Common Stock outstanding as of December 1, 2023, as reported by the issuer in the Form 10-Q.

(1) Based on 483,625,511 shares of Class A Common Stock outstanding as of December 1, 2023, as reported by the issuer in the Form 10-Q.

(1) Based on 483,625,511 shares of Class A Common Stock outstanding as of December 1, 2023, as reported by the issuer in the Form 10-Q.

(1) Based on 483,625,511 shares of Class A Common Stock outstanding as of December 1, 2023, as reported by the issuer in the Form 10-Q.

(1) Based on 483,625,511 shares of Class A Common Stock outstanding as of December 1, 2023, as reported by the issuer in the Form 10-Q.

(1) Based on 483,625,511 shares of Class A Common Stock outstanding as of December 1, 2023, as reported by the issuer in the Form 10-Q.

(1) Based on 483,625,511 shares of Class A Common Stock outstanding as of December 1, 2023, as reported by the issuer in the Form 10-Q.

This Amendment No. 2 (“Amendment No. 2”) amends the Schedule 13G initially filed with the United States Securities and Exchange Commission on February 14, 2022 and amended on February 14, 2023 (as amended, the “Original Schedule 13G”) by the Reporting Persons. The “Reporting Persons” are collectively, Accel Leaders Fund L.P. ("ALF"), Accel Leaders Fund Associates L.L.C. ("ALFA"), Accel Leaders Fund Investors 2016 L.L.C. (“ALFI16”), Accel Growth Fund IV L.P. (“AGF4”), Accel Growth Fund IV Strategic Partners L.P. (“AGF4SP”), Accel Growth Fund IV Associates L.L.C. ("AGF4A"), Accel Growth Fund Investors 2016 L.L.C. (“AGFI16”), Accel London V L.P. (“AL5”), Accel London V Strategic Partners L.P. (“AL5SP”), Accel London V Associates L.P. ("AL5A LP"), Accel London Investors 2016 L.P. (“ALI16”), Accel London V Associates L.L.C. ("AL5A"), Richard P. Wong ("RPW"), and Philippe Botteri ("PB"). Only those items that are hereby reported are amended; all other items reported in the Original Schedule 13G remain unchanged. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable. Capitalized terms not defined in this Amendment No. 2 have the meanings ascribed to them in the Original Schedule 13G.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5% of the class of securities, check the following: x

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 12, 2024

Entities:

Accel Leaders Fund L.P.**

Accel Leaders Fund Associates L.L.C**

Accel Leaders Fund Investors 2016 L.L.C.**

Accel Growth Fund IV L.P.*

Accel Growth Fund IV Strategic Partners L.P.*

Accel Growth Fund IV Associates L.L.C.*

Accel Growth Fund Investors 2016 L.L.C.*

Accel London V L.P.*

Accel London V Strategic Partners L.P.*

Accel London V Associates L.P.*

Accel London V Associates L.L.C.*

Accel London Investors 2016 L.P.*

Individuals:

Richard P. Wong*

Philippe Botteri*

* Signed pursuant to a Power of Attorney included herein as an exhibit to this Schedule 13G.

** Signed pursuant to a Power of Attorney already on file with the appropriate agencies.

EXHIBIT INDEX

EXHIBIT A

Agreement of Joint Filing

The Reporting Persons agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock of UiPath, Inc. shall be filed on behalf of each of the Reporting Persons. Note that copies of the applicable Agreement of Joint Filing are already on file with the appropriate agencies.

EXHIBIT B

Power of Attorney

KNOW ALL MEN BY THESE PRESENTS, that each undersigned hereby constitutes and appoints Ryan Connor his, her or its true and lawful attorney-in-fact to:

(1)            execute for and on behalf of each undersigned (each, a “Reporting Person”), individually or jointly with any other reporting persons, any and all reports, notices, communications and other documents (including, but not limited to, reports on Form D, Schedule 13D, Schedule 13G, Form 13-F, Form 3, Form 4, Form 5 and any applicable registration statements, notice filings or reports) that such Reporting Person may be required or requested to file with the United States Securities and Exchange Commission (the “SEC”) pursuant to the Securities Act of 1933, the Securities Exchange Act of 1934, the Investment Company Act of 1940 or the Investment Advisers Act of 1940, each as amended and with the implementing rules and regulations thereto (collectively, the “Reports”) with respect to a Reporting Person’s (a) status as an officer or director of, or (b) ownership of, or transactions in, securities of, any entity whose securities are beneficially owned (directly or indirectly) by such Reporting Person (each, a “Company”) or with respect to a Reporting Person’s obligation to register or otherwise provide filings or reports to the SEC;

(2)            do and perform any and all acts for and on behalf of each Reporting Person which may be necessary or desirable to complete and execute any such Reports and timely file such forms and schedules with the SEC and any stock exchange or similar foreign or domestic, federal or state authority; and

(3)            take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, such Reporting Person, it being understood that the documents executed by such attorney-in-fact on behalf of such Reporting Person, pursuant to this Power of Attorney, shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in her discretion.

Each Reporting Person hereby grants to such attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary, and proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as such Reporting Person might or could do if personally present, with full power of revocation, hereby ratifying and confirming all that such attorney-in-fact, or her substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. Each Reporting Person acknowledges that no such attorney-in-fact, in serving in such capacity at the request of such Reporting Person, is hereby assuming, nor is any Company hereby assuming, any of such Reporting Person’s responsibilities to comply with any such registration, filing or reporting requirements of the SEC or any stock exchange or similar foreign or domestic, federal or state authority, including without limitation Section 16 or Section 13 of the Securities Exchange Act of 1934 or otherwise.

This Power of Attorney shall remain in full force and effect with respect to a Reporting Person until the later of such time that (a) such Reporting Person is no longer required to file Forms 3, 4 and 5 or Schedules 13G/D with respect to such Reporting Person’s holdings of and transactions in securities issued by a Company, or (b) such Reporting Person is no longer required to file any other forms, registration statements or similar filings with the United States Securities and Exchange Commission or any other similar federal or state governmental entity, unless this Power of Attorney is earlier (i) revoked by such Reporting Person in a signed writing delivered to the foregoing attorney-in-fact or (ii) revoked by such foregoing attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 1^st day of February, 2024. This Power of Attorney may be executed in two or more counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument.